Oakworth Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Oakworth Capital’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.9K	Hold	56	–	–	﹤0.01%	519
2026 Q1	$43.3K	Hold	56	–	–	﹤0.01%	467
2025 Q4	$43.2K	Buy	56 +31	+124%	+$21.1K	﹤0.01%	455
2025 Q3	$14.1K	Buy	+25	New	+$14.1K	﹤0.01%	601
2023 Q4	–	Sell	-19	Closed	-$15.6K	–	714
2023 Q3	$15.6K	Hold	19	–	–	﹤0.01%	398
2023 Q2	$13.7K	Buy	+19	New	+$14.6K	﹤0.01%	422
2022 Q4	–	Sell	-707	Closed	-$487K	–	596
2022 Q3	$487K	Hold	707	–	–	0.05%	97
2022 Q2	$418K	Hold	707	–	–	0.04%	109
2022 Q1	$494K	Sell	707 -75	-10%	-$47.4K	0.04%	110
2021 Q4	$494K	Buy	782 +331	+73%	+$204K	0.04%	109
2021 Q3	$273K	Buy	451 +366	+431%	+$227K	0.03%	148
2021 Q2	$47K	Hold	85	–	–	﹤0.01%	321
2021 Q1	$40K	Buy	+85	New	+$41.4K	﹤0.01%	334
2019 Q2	–	Sell	-42	Closed	-$17K	–	646
2019 Q1	$17K	Hold	42	–	–	﹤0.01%	404
2018 Q4	$16K	Hold	42	–	–	﹤0.01%	399
2018 Q3	$17K	Hold	42	–	–	﹤0.01%	413
2018 Q2	$14K	Hold	42	–	–	﹤0.01%	438
2018 Q1	$13K	Hold	42	–	–	﹤0.01%	425
2017 Q4	$15K	Hold	42	–	–	﹤0.01%	413
2017 Q3	$21K	Buy	42 +40	+2,000%	+$19K	0.01%	406
2017 Q2	$1K	Hold	2	–	–	﹤0.01%	611
2017 Q1	$1K	Hold	2	–	–	﹤0.01%	615
2016 Q4	$1K	Hold	2	–	–	﹤0.01%	620
2016 Q3	$1K	Hold	2	–	–	﹤0.01%	595
2016 Q2	$1K	Hold	2	–	–	﹤0.01%	576
2016 Q1	$1K	Hold	2	–	–	﹤0.01%	531
2015 Q4	$1K	Buy	+2	New	+$1.08K	﹤0.01%	514

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Oakworth Capital's REGN Position: Q2 2026 in Review

Oakworth Capital held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 56 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Oakworth Capital first reported a position in REGN in Q4 2015 and has held it in 27 quarters since. The position peaked at $494K in Q1 2022. 344 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Oakworth Capital held 56 shares of Regeneron Pharmaceuticals worth $34.9K as of Q2 2026.
Oakworth Capital left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #519 holding.
Oakworth Capital first reported a position in Regeneron Pharmaceuticals in Q4 2015 and has held it in 27 quarters since.
Oakworth Capital's Regeneron Pharmaceuticals position peaked at $494K in Q1 2022.
344 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.